Beurer GL 50 (mg/dL) - Manual (Page 37)

Beurer GL50 mg/dL 37
Usage limits for specialist personnel from the healthcare sector:
1. If the patient exhibits the following symptoms, it may be the case that no correct values can be ob-
tained:
• Acute dehydration
• Acute hypotension (low blood pressure)
• Shock
• Hyperosmolar hyperglycaemic condition (with or without ketosis)
2. Lipaemic samples: cholesterol levels up to 500 mg/dL and triglycerid levels up to 1,000 mg/dL do
not influence the results. Severely lipaemic blood samples were not tested with the Beurer GL50
monitor; therefore, using the device with these samples is not recommended.
3. Blood glucose monitors designed for home use should not be used for severely ill patients.
4. The effect of interfering substances on the measurements depends on the concentration in the blood.
The maximum concentrations of certain substances listed below do not significantly influence the
measurements.
Blood glucose value
80 mg/dL 120 mg/dL 500 mg/dL
Concentration of
tested substances
Ascorbic acid 4.0 mg/dL 10.9% -1.8% 4.6%
Ibuprofen 50.0 mg/dL 3.1% 2.9% 4.6%
L-dopa 1.8 mg/dL 10.6% 7.9% 4.9%
Sodium salicylate 50.0 mg/dL -2.6% 9.4% -0.8%
Tetracyclin 1.5 mg/dL -5.3% 3.8% 3.2%
Tolbutamide 100.0 mg/dL -2.6% 12.3% 0.9%
Unconjugated bilirubin 2.4 mg/dL -2.5% 4.1% -0.2%
Uric acid 8.0 mg/dL 2.7% 9.6% -1.8%
Xylose 4.0 mg/dL 7.6% 0.8% 7.5%
Influence